Abbott Must Face Suit Over Anticonvulsant Birth Defect Risks

By Celeste Bott (June 23, 2022, 5:37 PM EDT) -- An Illinois appellate panel on Thursday reversed a summary judgment win for Abbott Laboratories in a suit brought by a couple claiming it failed to sufficiently warn physicians that its anticonvulsant drug Depakote could cause birth defects, ruling the suit wasn't barred by another case the couple filed against a Chicago hospital and its doctors.

Charles and Angie Muhammad's son was born with spina bifida in 2006, attributed to in utero exposure to Depakote, an anticonvulsant drug Angie was prescribed to treat schizoaffective and bipolar disorders. They first sued her physicians and Northwestern Memorial Hospital for medical negligence for prescribing Depakote...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!